Journal Home Online First Current Issue Archive For Authors Journal Information 中文版

Strategic Study of CAE >> 2012, Volume 14, Issue 8

Neutron capture therapy clinical development in the world

1. China Nuclear Industy Beijing 401 Hospital of China Institute of Atomic Energy, Beijing 102413, China;

2. Beijing Capture Technology Co. Ltd., Beijing 102413, China

Received: 2012-04-26 Available online: 2012-07-26 09:05:09.000

Next Previous

Abstract

Boron neutron capture therapy (BNCT) method was applied to about one thousand clinical patients and achieved good results internationally. In this paper, the principle of BNCT, the development history and international BNCT clinical progress were mainly introduced. The BNCT clinical treatment situation and evaluation in glioblastoma (GBM), malignant melanoma, recurrent head and neck cancer and metastatic liver cancer were discussed in detail.

References

[ 1 ] Locher G L. Biological effects and therapeutic possibilities of neu trons[J]. AmJ Roentgenol, 1936, 36: 1-13.

[ 2 ] Farr L E. Sweet W H, Robertson JS, et al. Neutron capture thera-py with boron in the treatment of glioblastoma multiforme[J]. Am J Roentgenol, 1954, 71: 279-291.

[ 3 ] Sweet W H. Practical problems in the past in the use of boron -slow neutron capture therapy in the trealment of glioblastoma multi-forme[C]//Fairchild R G, et al. Proceedings of the First Interna-tional Symposium on Neutron Capture Therapy. New York : Associ-ated Universities. INC,1983:376 -378.

[ 4 ] Hatanaka H. Boron Neutron Capture Therapy for Tumors [M].Asashimashi -dori Niigata, Nishimura, 1986.

[ 5 ] Synder H R , Reedy A J, Lennarz W J. Synthesis of aromatic bo-ronic acids, aldehydo boronic acids and a boronic acid analog of tyrosine [J]. J Am Chemsoc, 1958, 20: 835-838. link1

[ 6 ] Hatanaka H, Nakagawa Y. Clinical results of long -surviving brain tumor patients who underwent boron neutron capture therapy[J]. Int J Radiat Oncol Biol Phys, 1994,28 :1061-1066. link1

[ 7 ] Soloway A H, Hatanaka H, Davis M A. Penetration of brain and brain tumor. VII. tumor -binding sulfhydryl boron compounds[J]. JMed Chem, 1967,10: 714-717 link1

[ 8 ] Kleihues P, Cavenee W R. WHO classification of tumors pathology and genetics of tumors of the nervous system [M]. Lyon IARC Press, 2000:251 -253.

[ 9 ] Diaz AZ. Assesement of the results from the phase V/Il beron neu tron capture therapy trials at the Brookhaven national laboratory from a clinician´s point of view [J. Neurooncol ,2003,62:101-109. link1

[10] Busse PM. Harling 0 K. Palmer M R, et al. A critical exami-nation of the results from the Harvard -MIT NCT program phase elinical trial of neutron capture therapy for intracranial disease[J]. Neuroncol, 2003.62 :111-121.

[11] Wittig A. Hidephery K, Paquis P, et al. Current elinical results of the EORTC -study [C)//Sauerwein W. Research and Devel-opment in Neutron Capture Therapy. Bologna, Italy: Monduzzi Editore, 2002:1117-1122.

[12] Kankaanranta L, Seppila T, Koivunomo H, et al. L -boronophes nylalanine -mexliated born neutron caplure therapy for malignantglioma progressing after extemal beam radiation therapy: a phase I study 「J]. Radiati Oncol Binl Phys,2011 ,80:369-376. link1

[13] Henriksson R. Capala J. Michanek A. et al. Boron neutron cap-ture therapy (BNCT) for glioblastoma multiforme; a phase Ill study evaluation a prolonged high -dose of boronophenylalanine(BPA) [J]. Radiother Oncol, 2008,88 :183-191.

[14] Kawabata S, Miyalake S I. Kuroiwa T, et al. Roron neatrot capture therapy for newly diagnosed glioblastoma. [J]. Radiat Res,2009 ,50:51-60. link1

[15] Barth R F, Grecula JC. Yang W, et al. Combination of boron neutron capture therupy and external heamn rudiotherapy for brain tumors[J]. Int J Radiat Oncol Biol Phvs,2004,58:267-277. link1

[16] Yamamoto T. Boron neutron capture therapy for glioblastoma[C]//Shiam -Huei Jiang, Liu-Hao Yuan. The Front Edge of BNCT Development: Pnoeedings of the 6"Young Researchers Boron Neutron Capture Therapy Meeting. Taiwan(R.O.C.): National Tsing Hus University,2011:259-260.

[17] Miyatake S I, Kawabata S, Yokoyama K, et al. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas[J]. Neurooncol,2009,91:199-206. link1

[18] Yamamoto T, Nakai K, Nariai T, et al. The status of Tsukuba BNCT trial: BPA-based boron neutron capture therapy com-bined with X-ray irradiation[C]//Liberman S, et al. New Challenges in Neutron Capture Therapy 2010: Proceedings of the14th Intemational Congress on Neutron Capture Therapy. Buenos Aires,2010:7-8.

[19] Narayana A, Yamada J, Berry s, et al. Intensity -modulated ra-diotherapy in high-grade gliomas; clinical and dosimetric results[J]. Int J Radiat Oncol Biol Phys,2006,64(3):892-897. link1

[20] Worden FP, Moon J, Samlowski W, et al.A phase IⅡ evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck[J]. Cancer,2006:319-327. link1

[21] Lee N, Chan K, BekelmanJ E, et al. Salvage re -irradiation for recurrent head and neck cancer [J]. Radiat Oncol Bio Phys,2007:731-740. link1

[22] Kato I, Fujita Y, Maruhashi A, ct al. Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies[J]. Appl Radiat Isotopes,2009,67:37-42. link1

[23] Aihara T. BNCT for advanced head and neck carcinoma [C]//Shian-Huei Jiang, Liu-Hao Yuan. The Front Edge of BNCT Development: Proceedings of the 6h Young Researchers Boron Neutron Capture Therapy Meeting. Taiwan(R.O.C.): National Tsing Hus University,2011:6-7.

[24] Kankaanranta L, Seppala T, Koivunoro H, et al. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial[J]. Radiat Oncol Biol Phys,2011,82(1),67-75. link1

[25] Wang LW, Wang SJ, Chu PY, et al. Preliminary clinical ex-perience of boron neutron capture therapy for locally recurrent head and neck cancer at Tsing Hua open pool reactor[ C]//Shian-Huei Jiang, Liu-Hao Yuan. The Front Edge of BNCT Devel-opment: Proceedings of the 6h Young Researchers Boron Neutron Capture Therapy Meeting. Taiwan(R.O.C.): National Tsing Hus University,2011:257.

[26] Mishima Y. Neutron capture treatment of malignant melanoma using 10B-chlorpromazine pigment cell[J]. Res,1973,1:215-221. link1

[27] Hiratsuka J, Aihara T, Sasaoka S, et al. BNCT for skin cancer and advanced head and neck cancer in Japan [C]//Shian-Huei Jiang, Liu-Hao Yuan. The Front Edge of BNCT Development: Proceedings of the 6h Young Researchers Boron Neutron Capture Therapy Meeting. Taiwan: National Tsing Hus University,2011:85-86.

[28] Menendez PR, Roth BM C, Pereira M D, et al. BNCT for skin melanoma in extremities: updated Argentine clinical results[C]//Zonta A, et al.A New Option Against Cancer: Proceed ings of the 14th Intenational Congress on Neutron Capture Thera-py. Florence, Italy,2010:7-8.

[29] Zonta A, PinelliT, Prati U, et al. Extra-corporeal liver BNCT for the treatment of diffuse metastases: what was learned and what is still to be learned [J]. Appl Radiat lsotopes,2009,67:67- 75. link1

[30] Zhou Yongmao. Neutron capture therapy (NCT)& in -hospital neutron irradiator(IHN1)-a new technology on bincary targeting radiation therapy of cancer[J]. Enggineering Sciences,2009,7(4):2-21.

Related Research